Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Hoosier Cancer Research Network
QuantumLeap Healthcare Collaborative
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Rochester
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Baylor Research Institute
Fox Chase Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Vanderbilt-Ingram Cancer Center
Fudan University
University of California, San Francisco
Hebei Medical University Fourth Hospital
M.D. Anderson Cancer Center
Virginia Commonwealth University
UNICANCER
Virginia Commonwealth University
Spanish Breast Cancer Research Group
Korea University Guro Hospital
University Health Network, Toronto
University Health Network, Toronto
Peking University People's Hospital
Peking University Shenzhen Hospital
OHSU Knight Cancer Institute
West Cancer Center
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
City of Hope Medical Center
SOLTI Breast Cancer Research Group
Washington University School of Medicine
Jules Bordet Institute
Second Affiliated Hospital, School of Medicine, Zhejiang University
Institute of Cancer Research, United Kingdom
University of California, San Francisco
UNC Lineberger Comprehensive Cancer Center